文献速递神经肿瘤

生长性垂体腺瘤重复伽玛刀放射外科治疗后的长期肿瘤控制:一项基于人群的队列研究

Long-term tumor control following repeat gamma-knife radiosurgery of growing pituitary adenomas: a population-based cohort study.
PubMed 文献 · Acta Neurochir (Wien) · 2024-12-06

该单中心、基于人群的连续队列研究纳入1999至2022年在瑞典斯德哥尔摩卡罗林斯卡大学医院神经外科因肿瘤进展接受重复伽玛刀放射外科治疗的23例复发性垂体腺瘤患者,中位随访6.3年,5年无进展生存率为57%,重复伽玛刀放射外科至肿瘤进展的中位时间为2.6年,重复伽玛刀放射外科后肿瘤生长仅发生在治疗后的前三年内,重复伽玛刀放射外科时年龄较大是肿瘤持续生长的显著预测因素(OR 1.09,p=0.036)。

要点

  • 重复伽玛刀放射外科治疗生长性垂体腺瘤的5年无进展生存率为57%。
  • 重复伽玛刀放射外科后肿瘤进展的中位时间为2.6年,且肿瘤生长仅发生在术后前三年内。
  • 重复伽玛刀放射外科时年龄较大是肿瘤持续生长的显著预测因素(OR 1.09,p=0.036)。

核心结论

  • 重复伽玛刀放射外科是初始伽玛刀放射外科后出现生长的垂体腺瘤的一种可行治疗选择。

研究设计与样本

  • 单中心、基于人群的连续队列研究,纳入1999至2022年在瑞典斯德哥尔摩卡罗林斯卡大学医院神经外科因肿瘤进展接受重复伽玛刀放射外科治疗的复发性垂体腺瘤患者23例,中位随访6.3年。

主要发现

  • 5年无进展生存率为57%,重复伽玛刀放射外科至肿瘤进展的中位时间为2.6年。
  • 重复伽玛刀放射外科后肿瘤生长仅发生在治疗后的前三年内。
  • 重复伽玛刀放射外科时年龄较大是肿瘤持续生长的显著预测因素(OR 1.09,p=0.036)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gamma Knife radiosurgery (GKRS) is a well-established treatment for residual or growing pituitary adenomas (PAs) post-partial resection. However, some PAs grow even after initial GKRS, for which the efficacy of repeat GKRS is unclear. The primary objective of this study was to determine long-term progression-free survival (PFS) following repeated GKRS in patients with PA. The secondary objective was to determine predictors of tumor progression in these patients. METHODS: Single-center, population-based consecutive cohort study of patients with recurrent PAs treated with repeated GKRS due to tumor progression between 1999 and 2022 at the Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden. PFS and predictors of tumor growth were assessed. RESULTS: 23 patients were included, with a median follow-up time of 6.3 years. The 5-year PFS rate was 57%, and the median duration from repeat GKRS to tumor progression was 2.6 years. Tumor growth after repeat GKRS occurred exclusively within the first three years post-treatment. Older age at the time of repeat GKRS was a significant predictor of continued tumor growth (OR 1.09, p = 0.036). CONCLUSION: Repeat GKRS is a feasible treatment alternative for PAs that exhibit growth following initial GKRS.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Lindberg F, Gabri A, Kristiansson H, et al. Long-term tumor control following repeat gamma-knife radiosurgery of growing pituitary adenomas: a population-based cohort study. Acta Neurochir (Wien). 2024. PMID: 39641851. doi:10.1007/s00701-024-06341-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。